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ABSTRACT 
Animal models of human disease provide an in vivo system that can reveal molecular mechanisms by which 
mutations cause pathology, and, moreover, have the potential to provide a valuable tool for drug 
development. Here we have developed a zebrafish model of Parkinson’s disease (PD) together with a novel 
method to screen for movement disorders in adult fish, pioneering a more efficient drug testing route. 
Mutation of the PARK7 gene (DJ-1) is known to cause monogenic autosomal recessive PD in humans and, 
using CRISPR/Cas9 gene editing we have generated a DJ-1 loss of function zebrafish with molecular 
hallmarks of PD.  To establish whether there is a human-relevant parkinsonian phenotype in our model,  we 
have adapted proven tools used to diagnose PD in clinics and have developed a novel and unbiased 
computational method to classify movement disorders in adult zebrafish. Using high-resolution video 
capture and machine learning, we have extracted novel features of movement from continuous data 
streams and used an evolutionary algorithm (EA) to classify parkinsonian fish. This method will be widely 
applicable for assessing  zebrafish models of human motor diseases and provide a valuable asset for the 
therapeutics pipeline. In addition, interrogation of RNA-seq data indicate metabolic reprogramming of 
brains in the absence of DJ-1, adding to growing evidence that disruption of bioenergetics is a key feature 
of neurodegeneration. 
 
SUMMARY STATEMENT 
Computational analyses harness Artificial Intelligence to discriminate movement in a zebrafish model of 
Parkinson’s disease. 
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INTRODUCTION 
 
Parkinson’s disease (PD) is common, affecting about 1% of the population over 60 (Tysnes and Storstein, 
2017), and it has no cure. The incidence of PD increases with age, therefore this statistic is likely to become 
worse due to an aging population. Most cases of PD are not inherited, arising sporadically; however several 
monogenic forms of PD have been identified (reviewed in Hernandez et al., 2016).  Studying the genes 
disrupted in patients with inherited forms PD has been instrumental for the progress in understanding the 
molecular basis of the disease (Clark et al., 2006; Clements et al., 2006; Shimura et al., 2000).  
   
A valuable approach to understanding mechanisms by which gene mutations can result in human 
pathogenesis relies on in vivo experiments using animal models. Invertebrate models such as C.elegans 
(Ved et al., 2005) and Drosophila (Lu and Vogel, 2009) provide important platforms for studying 
neurodegenerative diseases in the context of a complete nervous system; however the genetically 
tractable vertebrate Danio rerio shares more features of neuroanatomy with humans.  Retrograde tracing 
has been used to identify dopaminergic (DA) neurons in zebrafish that project from the ventral 
diencephalon (vDC) to the ventral telencephalon (Rink and Wullimann, 2001). These neurons are sensitive 
to the neurotoxin MPTP (known to induce PD in humans) and considered analogous to the ascending 
midbrain DA neurons of the mammalian nigrostriatal pathway. In addition to anatomical similarities, 
vertebrate genomes share a high level of conservation such that orthologues of PD genes have been 
identified and manipulated in zebrafish  (Anichtchik et al., 2008; Bretaud et al., 2007; Flinn et al., 2009; 
Keatinge et al., 2015; Zhao et al., 2012). However, most of the zebrafish models of PD have used transient 
post-transcriptional gene inhibition protocols focusing on the analysis of larval DA neurons (Bretaud et al., 
2007; Flinn et al., 2009; Zhao et al., 2012) and swimming behaviour (Flinn et al., 2009; Zhao et al., 2012). In 
this paper we have developed an adult zebrafish model of PD that presents movement disorders typical of 
human patients. 
 
Loss of function mutations in PARK7 cause a rare form of early onset PD (Bonifati et al., 2003). PARK7 codes 
for the protein DJ-1 that has multiple roles in protecting cells from toxic protein aggregation and oxidative 
stress, and loss of these functions contribute to the presentation of parkinsonian pathology. DJ-1 protein is 
a member of a deeply conserved DJ-1/ThiJ/PfpI superfamily that includes related proteins from human to 
bacteria and archae (Bandyopadhyay and Cookson, 2004). While these homologues share a core structure, 
their diverse functions include acting as kinases, proteases and chaperones. In humans, DJ-1 has been 
found to prevent the aggregation of alpha-synuclein (Zondler et al., 2014), regulate transcription of 
oxidative stress response genes (Xu et al., 2005), and maintain mitochondrial function (Thomas et al., 2011; 
Winklhofer and Haass, 2010). High levels of oxidative stress in DA neurons is characteristic of PD patients, 
so it is interesting that DJ-1 itself is activated by the oxidation of a specific cysteine residue (C106) that is 
essential for its translocation to the mitochondria and neuroprotective function (Canet-Avilés et al., 2004; 
Wilson, 2011). Structural biology (reviewed Cookson, 2003) and Drosophila genetics (Oswald et al., 2018) 
have been particularly informative about the biochemistry and function of DJ-1, as a stable homodimer that 
acts as a redox sensor in neurons. 
 
The advent of simple and effective gene editing in vertebrates means that it is feasible to disrupt 
orthologues of known disease genes to model human disease; to this end we have created a null mutation 
in dj-1 in zebrafish. In order to assess whether this mutant provides a good animal model of human disease, 
we have developed a novel method to discern recognisable traits of the condition which will ultimately 
facilitate its use in developing treatments for improvement of symptoms. Neurodegeneration in PD is 
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characterised by bradykinesia, resting tremor, rigidity and postural instability (Jankovic, 2008); of these 
bradykinesia is a key indicative feature (Postuma et al., 2015). Recently, medical diagnosis of bradykinesia 
has been facilitated with a system called PD-Monitor that employs an evolutionary algorithm (EA) (a form 
of artificial intelligence or machine learning) to optimise predictive models capable of recognizing 
bradykinesia from finger tapping tasks (Gao et al., 2018). EAs can diagnose PD in humans with high 
accuracy from data collected using tracking sensors on the thumb and finger to extract movement data 
from a finger tapping exercise performed by PD patients and healthy age-matched controls. The movement 
data was used to train an EA which evolved classifiers with diagnostic accuracies of 80-90% (Lones et al., 
2013). Here we report how we have adapted these methods to assess movement in a zebrafish model of 
PD using a simple video set up and a computational platform that could be widely used for assessing motor 
impairment phenotypes in zebrafish. 
 
We have harnessed two powerful tools: gene editing to disrupt dj-1, generating an adult model of PD in 
zebrafish, and machine learning to evolve classifiers that discriminate movement data from our model. We 
find that training EAs with a continuous data stream mitigates bias, allows the computation of more wide 
ranging features, and can discriminate PD models from control zebrafish.  We report a bradykinesia-like 
movement disorder in this model of PD, as well as an RNA-seq analysis that indicates metabolic 
reprogramming in the absence of DJ-1. This novel and simple platform for discerning movement 
phenotypes has the potential to make important contributions to future drug development for movement 
disorders. 
 
 
RESULTS 
  
Gene targeting of dj-1 results in a null allele and loss of DA neurons 
A BLAST search was used to identify any orthologs of PARK7 (DJ-1) in the zebrafish and to compare the 
amino acid sequences of the encoded proteins. A single DJ-1 orthologue, containing 6 exons, was identified 
in zebrafish on chromosome 11 (ENSDARG00000116835). The 189 amino acid protein encoded by dj-1 in 
zebrafish shared 83% sequence identity with human DJ-1. Heterozygous dj-1 mutants were identified in the 
F1 generation with a 2bp deletion followed by a 19bp insertion in exon 2 at position 200 in dj-1 
(NM_001005938; chr11:41459837) (Fig. 1A). This resulted in a frameshift and a premature stop codon at 
nucleotide position 227. The predicted DJ-1 protein translated from the mutant transcript would be 56 
amino acids in length missing the essential C106 residue (Fig. 1B). The heterozygous  dj-1 zebrafish carrying 
this mutation were incrossed to create progeny (F2 generation) with 25% of the animals homozygous for 
the mutation. At maturity (16 weeks), Western blot analysis using an antibody known to recognise 
zebrafish DJ-1 (Bai et al., 2006) revealed a complete loss of the ~20kDa DJ-1 protein that is detectable in 
wild-type but not in dj-1
-/-
 mutant brains (Fig. 1C). qRT-PCR analysis was carried out on RNA extracted from 
the brains of 5 dj-1
-/-
 mutants and 3 wild-type siblings for gene expression analyses. qRT-PCR showed a 95% 
loss of dj-1 expression in the dj-1
-/-
 brains, indicating nonsense mediated decay of the transcript (Fig. 1D). 
Genes known to be expressed in (DA) neurons dat (dopamine transporter), th (tyrosine hydroxylase) and 
pitx3 (paired like homeodomain 3) were also found to be down-regulated in dj-1
-/-
 mutant brains compared 
to their wild-type siblings. dat and th expression were assessed as both are markers of dopamine neurons, 
dat is specific to dopamine neurons whilst th is expressed in all catecholaminergic neurons (Holzschuh et 
al., 2001). pitx3 is a transcription factor involved in the development and maintenance of dopamine 
neurons (Filippi et al., 2007).  We conclude that our targeting of dj-1 has resulted in a line of a genetic null 
zebrafish.  
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A PINK1
-/-
 mutant line was generated by CRISPR/Cas9 targeting of the PINK1 ortholog in zebrafish with two 
gRNAs producing a 101bp deletion in exon 2 of PINK1 (at position 591 of NM_001008628) (Figure 2H). The 
predicted PINK1 protein translated from the mutant transcript would be 183 amino acids in length losing 
the majority of the kinase domain and qRT-PCR analysis on RNA extracted from PINK1
-/-
 (n=4) and wild type 
sibling (n=3) adult brains revealed a ~90% loss of PINK1 expression, indicative of nonsense mediated decay 
of the mRNA. An immunohistochemical analyses was used to detect dopaminergic neurons (Figure 2); three 
brains were dissected from wild type, dj-1
-/-
 and PINK1
-/-
 zebrafish at 12 mpf and 100µm sections were cut 
with a vibratome through the posterior tuberculum (pT) in the diencephalon. In zebrafish, the posterior 
tuberculum includes a subset of dopaminergic neurons that project to the subpallium; these cells are 
considered homologous to the anteriormost ascending mesodiencephalic dopaminergic neurons in 
mammals (groups A8–A10) which are affected in PD (Rink and Wullimann, 2002, 2001) . To investigate 
whether these cells are impacted in our zebrafish models of PD, we used immunofluorescence to detect 
the protein tyrosine hydroxylase (TH), an enzyme required to produce catecholamines including dopamine. 
Our method is informed by the work of Matsui and Sugie (Matsui and Sugie, 2017) and Rink and Wullimann 
(2001) to identify and count these neurons in zebrafish. The brains were fixed and embedded in agarose 
blocks for vibratome sectioning before processing by IHC for TH immunoreactivity and imaging by confocal 
microscopy.  Cell bodies in the pT positive for TH that have a pear-shaped appearance and a periventricular 
position were identified as pT DA neurons and counted in each of the sections (Figures 2B-G and 2I-K). 
Figure 2L indicates the mean number of pT DA neurons identified for each genotype. In the wild type brain, 
a range of 4-5 of these cells were identified, consistent with the retrograde tracing study by Rink and 
Wullimann (2001), while the number of pT DA neurons identified in the dj-1
-/-
 and PINK
-/-
 brains ranged 
from 1-3 and 1-5 respectively, suggesting a reduction of these neurons in these genotypes, as shown 
previously for PINK1
 -/-
(Flinn 2013).  
 
A simple and effective method for measuring micro-movement in zebrafish 
A progressive loss of DA neurons is characteristic of PD in humans (Damier et al., 1999); however, to 
establish whether our dj-1
-/-
 null zebrafish provide a bone fide animal model of PD we wanted to test 
whether the fish share a dyskinesia phenotype. To do this, we have developed a new and simple method to 
measure features of movement. In contrast to other fish tracking programmes, our analysis extracts 
movement data from the adult tail bending along its whole axis while accelerating, decelerating, and 
turning. This data is collected as a continuous feed and converted by bespoke software into data suitable 
for use with novel computational methods to test whether our zebrafish model shows micro-movement 
features identified in human patients with Parkinson’s disease. 
 
We have established filming methods using a specially designed tank and camera setup that allows 
consistent video recordings free from reflections and shadows (Figure 3A).  We have also written a 
computer programme (ShadowFish) to generate a minimal set of data to characterise fish movement; this 
greatly reduces the dimensionality of the data which is essential for input into computational analyses. 
ShadowFish software and tank design is freely available (github.com/ghughesyork/ShadowFish). The 
position of the fish spine is approximated in each frame of an input video clip, and then the flexion or 
bending angle is measured at 5 equidistant positions along the spine (Figure 3B). 7 x,y coordinates were 
also measured along the spine for each frame. Simplifying the video data in this way facilitates our 
subsequent classification analyses using evolutionary algorithms. 46 dj-1
-/-
 mutant zebrafish (12 weeks old) 
and the same number of age-matched wild-type controls were recorded swimming for 5 minutes following 
an acclimation time of 10 minutes after moving into the ShadowFish tank. Using dj-1
-/-
 and wild type fish 
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from multiple different breedings reduced the chances of evolving a classifier that recognised a pattern 
occurring in a single progeny. The increased generality of the evolved classifier improves classification 
accuracy when used to discriminate future dj-1
-/-
 mutants. 30-second video clips, filmed at 100 frames per 
second, were processed from recordings. Two 30-second clips from each recording were processed using 
the ShadowFish software; these were visually assessed to ensure that we removed any video with a 
reflection or a shadow or where the fish was not in view. 30-second clips were also processed using the 
ShadowFish software to collect movement data in the same way from two other genotypes, PINK1
-/- 
and 
dmd
ta222a/+
. 
 
Extracting features of movement  
Initial analyses were undertaken using MATLAB to calculate selected features of movement including 
distance travelled (Figure 3C), velocity (Figure 3D), time spent moving (Figure 3E), and the swimming 
episode duration (Figure 3F).  Over a 30 second period, dj-1
-/-
 zebrafish covered significantly less distance at 
a slower velocity compared to wild-type fish. While wild-type spent 96% of their time moving, dj-1
-/-
 
mutants were moving only 83% of the time. Additionally, the mean swimming episode duration by a dj-1
-/-
 
was 17 seconds, compared to 25 seconds with the wild-type. Tail beat frequency (Figure 3G) and the mean 
tail bend amplitude (Figure 3H) were analysed at low, medium and high speeds of movement (Keatinge et 
al., 2015). It was hypothesised that mutant fish may need to work harder to achieve higher speeds through 
more tail beats however, only the tail beat frequency at low speed was significantly affected and reduced in 
the dj-1
-/-
 mutant. A trend was seen in the wild type zebrafish for the tail bend amplitude to decrease with 
an increase in swimming speed, suggesting that momentum allows fish to coast once higher speeds have 
been reached, reducing tail bend amplitude and energy expenditure (McHenry and Lauder, 2005). In 
contrast, the mean tail bend amplitude is significantly less in the dj-1
-/-
 zebrafish at low speeds but 
significantly greater at high speeds and a greater tail bend amplitude was observed in the DJ-1 deficient 
zebrafish at high speeds compared to the wild type (Figure 3H). As the dj-1-/- mutant fish stop more 
frequently (Figure 3F), the resulting inertia may impede them from gaining the momentum required for 
coasting. Alternatively, the dj-1
-/-
 zebrafish could lack the fine motor control required to moderate their 
swimming at speed. This is similar to the hypothesis that PD paents fail to appropriately scale the size of 
their movements to complete a given task (Mazzoni, Shabbo$ and Cortés, 2012). In contrast to the 
differences in movement seen at 12 wpf, we found that in younger zebrafish (8wpf) most features of 
movement of dj-1 mutants were not significantly different from age matched controls (Supplementary 
Figure 1). This progressive impairment of movement in dj-1
-/-
 mutant fish is consistent with the progressive 
loss of motor control seen in PD patients (Greffard, et al. 2006).  
 
Evolving classifiers using extracted features of movement  
Machine learning has proved successful in analysing highly complex, non-linear data in human PD patients 
(Lones et al., 2013) and we have adapted the methods from our previous study to this zebrafish model of 
PD.  Automated analyses of the digitised swimming data was used to measure selected features of 
movement in the mutant and wild-type fish with the aim to distinguish any combination of features that 
characterises the movement of the dj-1
-/-
 zebrafish. In addition, we have included data extracted from 
another parkinsonian model, the PINK1
-/- 
mutant zebrafish, and from zebrafish heterozygous for sapje 
(dmd
ta222a/+
) (Bassett et al., 2003).  sapje is a recessive mutation that is lethal when homozygous and a 
model for muscular dystrophy, another human disease where movement is disrupted. The dmd
ta222a
 allele 
is recessive so in a heterozygote condition there is no expected phenotype or expected change in 
movement, thus providing a negative control for evolving classifiers. 
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We describe here an objective method, using machine learning to identify any movement phenotype that 
can distinguish mutants from the wild-type with a defined level of accuracy. Machine learning can 
automatically analyse large data sets and ‘learn’ to recognise differences between the classes of data 
(Alpaydin, 2016) . We use a form of ‘supervised learning’, where a supervisor provides the desired output 
for every input when generating an optimised classifier (Ayodele, 2010). In this instance, the input is all the 
features of movement extracted from the recording of a fish and the desired output is the class of fish, 
either mutant or wild-type.  An evolutionary algorithm (EA) is a population-based process designed to 
optimise the solution to a defined problem; by evaluating a population of candidate solutions using a 
‘fitness function’ (an objective mathematical measure that determines the most effective solution) and 
subsequently spawning a new population of candidate solutions for the next generation. The EA goes 
through multiple generations and the candidate solution becomes increasingly optimised with each round 
of evolution. This culminates in an effective solution being produced and expressed as a discrete 
mathematical equation that describes the solution (Smith et al., 2015). Moreover, EAs are one of the few 
‘white box’ forms of machine learning where the functions that make up the classifier can be inspected 
(Lones et al., 2013); this is a useful characteristic to allow discovery of any movement phenotype 
characteristic of a zebrafish model of PD. 
 
Using selected features of movement, an EA was used to train classifiers labelling fish as either dj-1
-/- 
or 
wild-type. 46 dj-1
-/-
 and 46 age matched control zebrafish were recorded swimming for a period of 5 
minutes. Two separate 30-second clips were processed from each 5-minute recording generating 92 csv 
files containing raw movement data for each class of fish. After visual quality checks, 30 recordings of dj-1
-/-
 
and an equal number from age-matched wild-type controls were used to evolve classifiers. The type of EA 
used was a Cartesian Genetic Programming (CGP) algorithm where programs are represented as directed 
graphs with two-dimensional grids of computational nodes (Miller, 2011). CGP was selected as it is a “white 
box” machine learning algorithm that is both suitable for relatively small sample sizes and can provide 
insight to the contribution of respective features in the resulting classifier, as demonstrated in previous 
work in analysing human movement disorders (Lones et al., 2013). Here we use 30 recordings, 60 data 
points were obtained for each class, which according to Bland and Altman (2007, Section 3, method), 
provides a 95% confidence interval of ±0.44 standard deviations. The CGP network for classifying dj-1
-/- 
fish 
that achieved the highest test score on a fold of data sets is shown in Figure 4A. Velocity, mean tail beat 
frequency, and time spent moving where the extracted features of movement used in the highest scoring 
dj-1
-/-
 classifier. These data reveal these features of movement as the most useful for discriminating the dj-
1
-/-
 mutants from wild-type. The mean test score of classifiers evolved using the 20 folds of dataset was 
70%, indicating that an equation could distinguish dj-1
-/-
 fish by their features of movement 70% of the 
time. Similar analyses were carried out to classify extracted features of movement from PINK1
-/-
 (another 
PD model) and dmd
ta222a/+
 (a negative control), and are presented in Figure 4B and 4C. The EA was unable to 
compute an equation to distinguish these genotypes from controls using extracted features of movement 
(test scores are 51.6% and 43.5% respectively). 
 
Evolving sliding window classifiers from raw movement data 
For an unbiased classification we used the raw data extracted from the videos, without selection of any 
particular features of movement, for input into an evolutionary algorithm. To do this, we processed the 
movement data using Principal Component Analysis (PCA) to condense the data into principal components 
(PCs) by linear combination of the tail bend angles in each frame (Supplementary data, Figure 2).  This 
reduced the dimensionality of the tail bend angles, transforming the multivariate time series into a 
univariate time series whilst retaining the inherent variation of the data. PC2 was used to evolve classifiers 
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as it retained the high frequency movement and subtle variation important for characterising a movement 
phenotype (Lones et al., 2013). 
 
Sliding window classifiers, encoded using CGP, were evolved to classify the mutants using the PC2 time 
series as input data. The mathematical equations generated describe local patterns in the movement data 
that can be used for discrimination (Lones et al., 2013). The window in a sliding window classifier contains 
the data from a specific range in a time series, which becomes the input data for the evolved algorithm. 
The raw movement data extracted from 36 clips of dj-1
-/-
 mutants and 64 clips of age matched control 
zebrafish with visually assessed, high quality tracking were used to evolve sliding window classifiers. Here, 
20 PC2 values (extracted from 20 frames of a recording) were used as the input data for a window. The 
algorithm applies predefined functions to the input data and produces a continuous value between 0 and 1 
(Lones et al., 2013). Subsequently, the window slides along one position in the time series to get the next 
overlapping range of data points. The algorithm is applied to the new input data and produces a further 
output value, the process is repeated until the sliding window has reached the end of the time series. The 
final classifier output (the mean of all the output values) labels the data as belonging to one of two classes 
depending on a threshold value. Similar analyses were carried out on the PINK1
-/- 
homozygous mutants and 
dmd
ta222a/+
 heterozygote zebrafish.  
 
One of the aims of this work was to confidently classify zebrafish using a protocol that is effective and 
practical, by acquiring short 5-minute videos for analysis. Two 30 second clips were determined empirically 
to provide sufficient data to identify differences in movement that allow classification of both the dj-1
-/-
 and 
PINK1
-/-
 mutants from control fish. For the dj-1
-/-
 and PINK1
-/-
 datasets, the sliding window classifiers were 
able to discriminate mutant fish around 80% of the time (Figure 4 D,E). The classifiers evolved using the raw 
movement data were more effective than classifiers evolved using select features. This is likely due to the 
objectivity that is possible using a continuous stream of data as well as the increased amount of data 
analysed from each recording. In addition, each selected feature was calculated to a single value 
summarising the movement in a video clip and reducing the data available to the EA. To visualise local 
patterns in the movement data characteristic of each class of fish (mutant (red) or wildtype (black)) a mean 
plot of the 20 windows that were most useful for discriminating mutants is shown for dj-1
-/-
 (Figure 4D) and 
PINK1
-/-  
(Figure 4E) mutant zebrafish. This same set of computational analyses was undertaken using 
heterozygous dmd
ta222a/+
 zebrafish and a useful classifier could not be evolved. Supplementary Figure 5 
reports the training and test AUCs (area under the curve) for 20 runs, showing a mean of 0.78 for train and 
0.43 for test. This shows that classifiers are evolved that over-fit the training data, but these models cannot 
generalise or classify any meaningful differences between the movement of dmd
ta222a/+ 
and the wild-type 
zebrafish.  Together, these data indicate that machine learning can discriminate movement phenotypes 
when present, as is the case with the zebrafish models of PD, but not in the heterozygous carrier of the 
muscular dystrophy gene dmd
ta222a/+
 that has no phenotype; this was expected given the recessive 
inheritance of the disease. One limitation of our study is that we do not treat adult animals with drugs; for 
instance, MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) treatment mimics PD which would be a 
useful addition to our protocols. Moreover, the ability of AI to identify PD fish presents the possibility 
(indeed the next step) of treating the fish with known or potential therapeutics and then re-assessing the 
same fish. We are currently working with collaborators to develop these further protocols.  
  
Molecular signatures consistent with Parkinsonian pathology characterise dj-1
-/-
 brains 
Animal models can provide important insight into the molecular basis of genetic disease. To investigate any 
global changes in gene expression associated with a loss of DJ-1, RNA-Seq was carried out on RNA extracted 
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from adult zebrafish brains using dj-1
-/-
 mutants and 3 wild-type siblings at 16 weeks post fertilisation. An 
overview of these effects is shown as a volcano plot (Figure 5A) and a short list of affected genes was 
curated using the criteria of fold-change ≥ 1.2 (up- or down-regulated) and FDR-adjusted p-value ≤0.05.  
The list is depicted as a heat-map illustrating the relative expression of 22 transcripts that were found to 
have significantly altered expression in the dj-1
-/-
 mutant brains (Figure 5B). Validation of a set of these 
targets by qRT-PCR analysis confirmed the changes in expression for some genes of interest (Fig. 5C). These 
data have been deposited in NCBI's Gene Expression Omnibus (Edgar, Domrachev and Lash, 2002) 
accession number GSE135271 (https://www.ncbi.nlm.nih.gov/geo). A list of all differential transcripts with 
q<0.05 is provided in the supplementary data (Tables 2A and 2B). 
 
Genes significantly affected by a loss of DJ-1 include those with cell functions known to be disrupted in PD. 
Vamp3, part of a SNARE complex, found on the vesicle membrane and required for vesicular transport from 
early, recycling endosomes to the trans Golgi network was found down-regulated (Mallard et al., 2001). 
The SNc dopamine neurons have increased vulnerability to dysfunctional intracellular trafficking, as vesicles 
transport cargo great lengths and to a high number of synapses due to their extensive axonal arborization 
(Bolam and Pissadaki, 2012; Giguère et al., 2019). Mitochondrial dysfunction is accepted as central to PD 
pathophysiology (Hu and Wang, 2016). Here we find that glycine amidinotransferase (gatm), a 
mitochondrial enzyme involved in creatine synthesis (Sandell et al., 2003), is significantly down-regulated in 
dj-1
-/-
 brains. As well as an energy store, creatine has an anti-oxidative function scavenging for reactive 
oxygen species (Allen, 2012; Gabriel et al., 2013). In addition, glutathione peroxidase 3 (gpx3), an enzyme 
that reduces hydrogen peroxide thereby protecting the cell from oxidative stress, also has reduced 
expression in the brains of dj-1
-/-
 zebrafish. Interestingly, the human GPx3 gene contains a peroxisome 
proliferator response element (PPRE) that is activated by PPARγ (Chung et al., 2009), a signalling pathway 
found activated downstream of DJ-1 (Han et al., 2018). Pyruvate kinase M1/2, a key regulator of aerobic 
glycolysis (Sun et al., 2011), is also down-regulated suggesting dysregulated metabolism in dj-1
-/-
 brains. 
 
In order to take a broader view of the classes of genes sensitive to loss of DJ-1, we used Gene Set 
Enrichment Analysis (GSEA) to analyse our RNA-Seq data (Subramanian et al., 2007, 2005) and found 
enrichment profiles consistent with disrupted metabolism and cell cycle regulation. This method uses pre-
defined sets of genes that have been categorized based on interactions in a common pathway or a related 
biological function. The data from the RNA-Seq analysis was processed and a normalised enrichment score 
(NES) calculated to determine whether genes affected are over-represented in any molecular signature 
database. The NES reflects the degree to which the genes in a gene set are over-represented at the top or 
bottom of a gene list ordered by association with a genotype. Our results reveal dj-1
-/-
 brains have over-
representation of the gene sets presented in Table 3 (Supplementary data). As would be predicted from 
several previous reports (Kim et al., 2005; Lan et al., 2017), we find enrichment of gene sets associated with 
PI3K/AKT/mTOR and mTORC1 signalling (Figure 5D and Table 3). This is consistent with increased levels of 
mTOR in mouse models of PD (Wills et al., 2012) and the finding that DJ-1 negatively regulates the tumour 
suppressor PTEN, which is part of the PI3K/AKT signal transduction pathway (Kim et al., 2005).  
 
Our GSEA also indicates an up-regulation of genes associated with oxidative phosphorylation in the absence 
of DJ-1. Metabolic regulation in neurons is crucial given the high and dynamic energy demands of the 
vertebrate brain (Yellen, 2018); moreover, SNc DA neurons in particular have high metabolic needs 
(Giguère et al., 2019). Our results show that some genes coding for players in glycolysis (Figure 5C) are 
downregulated while the gene set for oxidative phosphorylation is over-represented (Figure 5D and Table 
3).  We also find the enrichment of the G2 to M transition gene set and targets of E2F transcription factors 
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(Figure 5D), as well as other cell cycle related genes sets (Table 3) in brains of dj-1
-/-
 zebrafish. Interestingly, 
entering the cell cycle has been linked to cell death in neurons (Herrup et al., 2004; Herrup and Yang, 
2007), and moreover, Höglinger et al. (2007) found that the pRb/E2F pathway caused neuronal cell death in 
a chemical model of PD, consistent with the over-representation of mitotic gene sets in dj-1
-/-
 brains 
reflecting their neurodegenerative pathology. 
 
DISCUSSION 
 
Age-dependent neurodegeneration is difficult to model in organisms with short lifespans, and moreover, 
motor disorders are not always apparent and can be difficult to measure (Lee et al., 2017; Rousseaux et al., 
2012).  There has been some success modelling PD using neurotoxin-based models in the mouse, however 
these present a rapid loss of DA neurons, which does not align with the progressive neurodegeneration of 
PD in humans (Jackson-Lewis and Przedborski, 2007). Genetic approaches in modelling PD in mice have had 
less success in reproducing the neurodegeneration. The loss of PINK1, Parkin, Dj-1 or Fbxo7 in the mouse 
does not reduce the number of nigrostriatal DA neurons or locomotor ability (Gispert et al., 2009; Kim et 
al., 2005; Perez and Palmiter, 2005; Vingill et al., 2016). A further triple knockout of PINK1, Parkin and Dj-1 
in the mouse still failed to produce a phenotype with recognisable aspects of PD (Kitada et al., 2009). In 
contrast, transgenic expression of genes associated with autosomal dominant PD in humans, LRRK2 
(G2019S) and SNCA, was shown to cause a loss of nigrostriatal DA neurons and locomotor defects in the 
mouse (Ramonet et al., 2011; Janezic et al., 2013). In addition, aggregates of alpha-synuclein forming in the 
motor neurons of transgenic mice overexpressing alpha-synuclein has been reported, which could impact 
on the movement phenotype (van der Putten et al., 2000). Rats may prove a better mammalian model for 
PD; Dave et al. (2014) reported a loss of DA neurons and locomotor defects in rats lacking Dj-1 and PINK1, 
but not parkin. Overexpression of LRRK2(G2019S) and SNCA in the rat brain has been able to cause a loss of 
the nigrostriatal DA neurons in some cases (Dusonchet et al., 2011; Lo Bianco et al., 2002). Nonetheless, 
compared to a mouse or rat models, there are advantages to using zebrafish in drug screens. Zebrafish are 
smaller, have lower maintenance costs and produce much larger broods for generating large numbers of  
animals for analyses; there is also the simplicity of administering candidate drugs in their water. While the 
method described here uses adults and is not suitable for the high-throughput drug screens used on 
zebrafish larvae (Gallardo et al., 2015), it may provide a valuable addition to current drug screening 
protocols targeted at genetic diseases that have no larval phenotype but present a later movement 
disorder, as part of a multifaceted approach  (Volpatti et al., 2020).  
 
 
An unbiased method to discriminate movement disorders in zebrafish 
Here we have used an evolutionary algorithm to classify data obtained from recordings of zebrafish 
movement by measuring the bending of the spine. Previous tracking software has analysed location 
coordinates as fish swim; this is done in larvae and adults and informs only on the location or locomotor 
activity of individuals or groups of fish (Stewart, Gerlai and Kalueff, 2015; Cronin and Grealy, 2017). In 
contrast, we have measured the tail bend angle along the back of individual adults, to inform on muscle 
movement and assess dyskinesia. Using this approach, machine learning discriminates a Parkinsonian 
phenotype in zebrafish deficient in dj-1/PARK7, a gene that causes a recessive form of early onset PD in 
humans. Off-target effects are a worry of any experimental programme that relies on gene targeting. Back 
crossing to the wildtype strain for several generations can remove any potential modifiers linked to the 
targeted gene and extending our study in this way would ensure that the movement phenotypes 
distinguished in our analyses tracked with the mutant allele. It is also important that the fish are 
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genetically similar except for the allele of interest making it difficult to compare across different 
generations, therefore the fish compared were always cousins of the same generation. In addition, raising 
fish in separate tanks and the emergence of traits from unrelated homozygous mutations resulting from in-
crossing wildtype fish are potential caveats to our interpretations. Nonetheless, machine learning was able 
to distinguish dj1
-/-
 and PINK1
-/- 
mutants from wildtype cousins, but could not evolve an equation to 
discriminate between our control line, dmd
ta222a/+ 
heterozygotes, from wildtype fish which were also raised 
in separate tanks. 
 
Machine learning has also been used to classify mouse models of PD generated by injection of neurotoxins 
directly into the brain; the pronounced movement phenotype is measured using the well-established 
Noldus Catwalk gait analysis and discriminated with an accuracy of 96% (Frohlich et al., 2018). Similarly,  
the extraction of movement data and evolution of classifiers to diagnose PD in humans has been refined to 
reach accuracies of up to 95% (Lones et al., 2013).  Our novel ShadowFish tracking software extracts data 
suitable for analysis by evolutionary algorithms and results in classifiers with ~80% accuracy.  The ability of 
our new method to evolve algorithms that discriminate movement of zebrafish carrying two different PD 
but not that of zebrafish carrying a heterozygous mutation in dmd, indicates our method has the potential 
to reach higher classification accuracies and provide a valuable new method to detect movement disorders 
in a non-mammalian vertebrate model. 
 
Clinical diagnosis of PD is challenging, with an accuracy of about 80% (Hughes et al., 1992; Rizzo et al., 
2016). More accurate, less subjective diagnosis of PD using EAs has improved diagnostics and is able to 
describe the bradykinesia characteristic of PD in a finger tapping exercise (Lones et al., 2013), allowing early 
diagnosis of PD distinct from other neurodegenerative diseases. Our adaptation of this technology to 
evolve classifiers that identify mutant zebrafish based on movement data will provide a method to screen 
for drugs that improve the movement phenotype. We have found that  DJ-1 deficient zebrafish display an 
overall loss of movement measured as a reduction in distance travelled, velocity, time spent moving and 
duration of a swimming episode; comparable to the bradykinesia observed in PD patients (Jankovic, 2008). 
Furthermore, the shorter duration of swimming episodes indicated more frequent periods of inactivity; 
akin to the freezing episodes observed in PD (Chee et al., 2009). There is, however, a deal of subjectivity 
when studying features selected based on conventional movement measures. In comparison, the sliding 
window classifier is much more objective, automatically extracting features based on minute differences in 
movement that are undiscernible to the human eye, rather than the general features of movement. On 
examination of the input video data, we find that the discriminating classifiers often use data from when 
the fish turns. This suggests that the movement phenotype in Parkinsonian zebrafish is similar to that found 
in PD patients where bradykinesia is particularly evident when turning around, for example (Chou and Lee, 
2013).  A further consideration to take into account is that a muscle disorder might be contributing to the 
movement phenotype, as loss of dj-1 has been found to affect metabolic respiration in skeletal muscle cells 
and result overall reduced body mass (Edson et al., 2019).  
 
Molecular signature of a PD brain: increased oxidative phosphorylation and cell cycle re-entry 
Confirmation of a valid parkinsonian model was provided by gene set enrichment analysis (GSEA) 
(Subramanian et al., 2005) that revealed molecular signatures described in other genetic models of PD. The 
DJ-1 protein is sensitive to ROS (Canet-Avilés et al., 2004; Mitsumoto et al., 2001) acting as a 
neuroprotector by quenching excess ROS at the mitochondrial membrane (Taira et al., 2004) and is also 
required for the subcellular localisation of hexokinase (HK1) to the mitochondria (Hauser et al., 2017). This 
links DJ-1 activity directly to mitochondrial function, alongside other notable autosomal recessive PD genes 
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PINK1 and Parkin that monitor and maintain mitochondrial function. Mitochondrial dysfunction is accepted 
to be a major factor in the pathology of PD (reviewed Cookson, 2012), although it is puzzling how defective 
mitochondria, an organelle essential in all cells, leads to the specific depletion of SNc DA neurons. One 
explanation is that the high number of synapses associated with these neurons results in extraordinarily 
high energy demands (reviewed Bolam and Pissadaki, 2012); indeed, there is a higher basal rate of 
mitochondrial oxidative phosphorylation in SNc DAs compared to dopaminergic neurons of the ventral 
tegmental area (Pacelli et al., 2015). Recently, good evidence for this hypothesis has been provided by the 
Trudeau lab when they showed that a mouse engineered with increased axonal arborization of SNc DA 
neurons is more vulnerable to PD causative neurotoxins (Giguère et al., 2019). Our findings that genes 
associated with oxidative phosphorylation are altered in the dj-1
-/- 
zebrafish is consistent with the notion 
that disruption of bioenergetics is a key feature of a neurodegenerative brain. 
 
Upregulation of genes associated with oxidative phosphorylation in a mouse Parkin
-/- 
 model (Giguère et al., 
2018) and a zebrafish dj-1
-/-
 model of PD has been described (Edson et al., 2019), while dysregulation of 
genes associated with metabolism is consistent with a neurodegenerative state in PD (Giguère et al., 2018; 
Shi et al., 2015) as well as Alzheimer’s disease (Demetrius et al., 2015). One interpretation (Yellen, 2018) is 
that the high energy demands in neurons requires the uncoupling of glycolysis and oxidative 
phosphorylation, and it may be that DJ-1 is required for this switch. Another interpretation is that 
neurodegeneration results from an ‘Inverse Warburg effect’; this has been proposed as a cause of sporadic 
Alzheimer’s disease where oxidative phosphorylation is up-regulated in aging or otherwise impaired 
neurons as a compensatory response to meet energy needs (Demetrius et al., 2015), an idea supported by 
our data that oxidative phosphorylation genes are enriched in the absence of DJ-1.  
 
GSEA also reveals that in zebrafish brains lacking DJ-1, there is an enrichment of genes associated with 
mitosis, such as those regulating the G2/M checkpoint, E2F target genes, as well as the cancer related gene 
sets associated with epithelial mesenchymal transition, Myc targets, and the mitotic spindles. This may 
seem surprising, since DJ-1 was first identified by its interaction with c-Myc and indeed can transform 3T3 
cells when co-expressed with c-Myc or ras (Nagakubo et al., 1997). However, PD genes have been 
implicated in cell cycle control (reviewed West et al., 2005) and the re-activation of cell cycle proteins 
(including the E2F factors) has been detected in tissue from PD patients (Höglinger et al., 2007). Post-
mitotic neurons have mechanisms in place that prevent cell cycle progression and re-entering the cell cycle 
can lead to apoptosis; this may be a mechanism underlying neurodegeneration (reviewed Folch et al., 2012; 
Herrup et al., 2004; Herrup and Yang, 2007). We conclude that the over-representation of mitotic gene 
sets, together with those indicative of altered metabolism, reflects the neurodegenerative state of dj-1
-/-
 
zebrafish brains.  
 
Machine learning can contribute to drug development 
To date most zebrafish models of PD have been transient models in larvae, generated using neurotoxins 
such as MPTP which cause a rapid loss of the DA neurons (Bretaud et al., 2004; Feng et al., 2014) or by 
morpholino knockdown of PD-associated genes (Bretaud et al., 2007; Flinn et al., 2009; Zhao et al., 2011), 
in addition an adult PINK1
-/- 
mutant zebrafish has been described (Flinn et al., 2013). A few studies have 
tested potential therapies on zebrafish models of PD by measuring the distance travelled and velocity of 
larvae (Cronin and Grealy, 2017; Sheng et al., 2010). PD in humans is both age-related in nature and 
characterised by a movement phenotype of bradykinesia (slowing of movement), resting tremor and 
muscle rigidity (Jankovic, 2008). Given the progressive loss of DA neurons, an adult model of PD is 
intuitively more suitable and evolving classifiers using tail bend data provides a more comprehensive, 
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unbiased assessment of the movement phenotype. The novel use of machine learning described here has 
the potential to accelerate the drug discovery pipeline (Lam and Peterson, 2019) by allowing more 
comprehensive screening using non-mammalian vertebrate models of movement disorders. 
 
MATERIAL and METHODS 
 
gRNA design 
A synthetic guide RNA (gRNA) was designed to target Cas9 cleavage in park7/dj-1 upstream of the codon 
for residue C106, in order to produce an early stop codon and loss of C106 from the translated protein. This 
cysteine is critical for the oxidative stress response of DJ-1 (Wilson, 2011). The online CRISPR design tool 
ChopChop (https://chopchop.rc.fas.harvard.edu/) was used to identify a target sequence near the start of 
the dj-1 coding sequence. A 20bp target sequence (5’- GCCGGTTCAGTGCAGCCGTG-3’) in exon 2 of dj-1 was 
selected and incorporated into the forward primer for gRNA production. A promoter sequence for 
increasing transcription efficiency with T7 RNA polymerase was added to the 5’ end of the forward primer 
along with an additional G nucleotide necessary for the T7 polymerase to work (Nakayama et al., 2014). 
This resulted in the following forward primer sequence: 5’- GCAGCTAATACGACTCACTATAGGC 
CGGTTCAGTGCAGCCGTGGTTTTAGAGCTAGAAATAGCAAG-3’. PINK1 was distupted using the same approach, 
with the modification of two gRNAs were designed 100bp apart pink1(1) 5’- GCAGCTAATACGACTCA 
CTATAGGGTGAAGCAGAAAGTCGAAGGTTTTAGAGCTAGAAATAGCAAG-3’ and pink1(2) 5’-GCAGCTAA 
TACGACTC ACTATAGCGCAGCTGTTTATGAGGCTGGTTTTAGAGCTAGAAATAGCAAG-3’. The reverse primer 
used for gRNA synthesis is common for all gRNAs: 5’-AAAGCACCGACTCGGTGCCACTTTTT 
CAAGTTGATAACGGACTAGCCTTATT TTAACTTGCTATTTCTAGCTCTAAAAC-3’ (Nakayama et al., 2014). For 
genotyping, the primers to amplify dj-1 genomic region: (For 5’-GGCTCTGGCCATCATTACTAT-3’; Rev 5’-
GTAAAGTCAGACCTGTTTGTGTG-3’) and primers to amplify PINK1 genomic region: (For 5’- 
GGCTGTATTTAGAAAGAAGAAGTTTCAG-3’; Rev 5’-GCAGCACAGTACAATTGTCAACTATAAA-3’). 
 
Generating mutant lines 
The strain of zebrafish used was London Wild Type (LWT) and both males and females between 8 and 14 
weeks post fertilisation were analysed for movemnt phenotypes. Transcriptomic analyses were carried out 
on the brains of zebrafish at 16 wpf and the immunohistochemical analysis was carried out on the brains of 
zebrafish at 12 mpf. This study was carried out using procedures authorised by the UK Home Office in 
accordance with the Animals Scientific Procedures Act (1986) and approved by the Animal Welfare and 
Ethical Review Body at the University of York and the UK Home Office. 
 
Cas9 protein was co-injected with dj-1 targeting sgRNA into single cell embryos from the LWT zebrafish 
strain to produce the F0 fish that were outcrossed with wild-type to generate heterozygous F1 mutants. 
Genotyping of the F1s revealed a male and female carrying the same mutation in dj-1; these heterozygotes 
were in-crossed to produce the F2 generation. F2 zebrafish homozygous for dj-1 were out-crossed with 
wildtype to generate a stock of heterozygous fish (F3), these were in-crossed and the offspring raised 
together (F4), genotyped and used for molecular analysis and generating a stocks of homozygous and 
wildtype fish for movement analysis. Genotyping the dj-1 locus in zebrafish was carried out by PCR of the 
target region followed by BbvI restriction digest assay; digestion of wild-type dj-1 amplicon results in 
products of 214bp and 55bp in length. The BbvI restriction site is lost in the mutated dj-1 so the PCR 
product remains 286bp in length. PINK1 was disrupted using two gRNAs were designed 100bp apart 
resulting in a 101bp deletion detectable by gel electrophoresis following PCR of the target region. The 
breeding strategy was the same as described above. 
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Western Blotting 
Zebrafish brains were dissected from adults and flash frozen in liquid nitrogen before storing at -80°C. 
Frozen brains were homogenised in 100μl of lysis buffer consisting of 50mM Tris-HCl (pH 7.4), 10mM 
sodium glycerophosphate, 10mM sodium pyrophosphate, 150mM NaCl, 5mM MgCl
2
, 1mM EDTA, 1mM 
DTT, 1% Triton X-100, 10% glycerol, 1mM sodium orthovanadate and cOmplete
™
Mini EDTA-free Protease 
Inhibitor Cocktail (Roche). The lysate was centrifuged at 13,000 rpm for 10 minutes prior to running on a 
12% SDS-PAGE gel. After transfer to a PVDF membrane, immunodetection used the anti-DJ-1 pAb (PA5-
72638, Invitrogen) and anti-GAPDH mAb (G8795, Sigma-Aldrich), both at a dilution of 1:50,000. HRP-linked 
anti-rabbit IgG (7074, Cell Signaling Technology) and HRP-linked anti-mouse IgG (62-650, Invitrogen) at 
concentrations of 1:2,000 and 1:4,000 respectively. 
 
Quantitative reverse transcription PCR 
Zebrafish brains were dissected out of adults before homogenising in 1ml of TRIzol reagent (Sigma) for RNA 
extraction. Following centrifugation at 4°C for 10 minutes at 13,000 rpm, RNA was purified from the upper 
aqueous phase using the RNA Clean & Concentrator kit (ZYMO) following the manufacturer’s instructions. 
cDNA was synthesised from 1μg of RNA by reverse transcription using Superscript IV Reverse Transcriptase 
(Thermo Fisher Scientific) following the manufacturer’s instructions with random hexamer primers. Primers 
were designed to amplify a product of 50-150bp with one primer in each pair crossing an exon junction 
(Table 1). Each qPCR analysis was carried out with a minimum of 3 biological replicates and 3 technical 
repeats. The mean cycle threshold (Ct) value was normalised to the Ct of reference gene ef1] generating a 
delta-Ct (dCt) value for genes of interest. Delta-delta-Ct (ddCt) values were then calculated by subtracting 
the dCt values of wild type siblings from mutants and the relative fold change was equal to 2^(-ddCt). 
Student t-tests were carried out comparing the dCt values of mutants and wild type siblings for each gene. 
GraphPad Prism5 was used to generate graphs showing the relative fold change with error bars 
representing standard error of the mean (SEM).  
 
Immunofluorescence 
Adult zebrafish were euthanised at 12 mpf, whole brains were extracted and fixed overnight at 4°C in a 4% 
PFA/PBS solution. Brains were washed twice in PBS for 10 minutes. Brains were then sectioned transversely 
in 3% agarose/PBS by vibratome at a thickness of 100μM. Based on the protocol by (Matsui and Sugie, 
2017) brains were incubated in 10 mM sodium citrate buffer (pH 8.5) for 2 hours at 80°C. Sections were 
washed twice in PBS with 1% TritonX-100 (PBS/1% Tx) for 15 minutes. Sections were then blocked in 2% 
BSA / PBS / 1% Tx for 30 minutes. After blocking, sections were incubated overnight at 4°C with a 1:500 
dilution of mouse anti-TH (#22941, Immunostar) in 2% BSA / PBS / 1% Tx. Sections were then washed four 
times in PBS / 1% Tx for 30 minutes. Sections were incubated overnight at 4°C with a 1:500 dilution of goat 
anti-mouse IgG1 conjugated to Alexa Fluor 488 (A21121, Invitrogen) in 2% BSA / PBS / 1% Tx. Sections were 
then washed four times in PBS / 1% Tx for 30 minutes. Staining for nuclei was carried out by incubating the 
sections in 1μg/ml Hoecshst 33342 in PBS / 1% Tx for 10 minutes. Sections were then washed four times in 
PBS / 1% Tx for 30 minutes. Sections were mounted on 15mm cavity microscope slides before imaging.  
 
RNA-seq  
RNA was extracted and purified as described above from the brains of 3 dj-1
-/-
 mutants and 3 wild-type 
siblings at 16 wpf. A NanoDrop ND-1000 Spectrophotometer was used to quantify each RNA sample and 
the RNA integrity was measured using an Agilent 2100 Bioanalyzer. The NEBNext® Poly(A) mRNA Magnetic 
Isolation Module was used to isolate mRNAs from the total RNA before preparing cDNA libraries using the 
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NEBNext
®
 Ultra RNA Library Prep Kit for Illumina
®
 following the manufacturer’s instructions. Unique adaptor 
sequences were added to the fragments in each cDNA library before pooling them together. The pooled 
cDNA libraries were then sequenced using 2 x 150 bp paired end reads on 1 lane of an Illumina
®
 HiSeq 3000 
system. Cutadapt 1.16 was used to trim the adaptor sequences from each read. The fastq files generated 
were then aligned to the genome assembly GRCz11, the transcriptome was annotated using RefSeq (NCBI) 
and transcript abundance was quantified using Salmon 0.10.2. Differential expression analysis was then 
carried out on the aligned transcripts using Sleuth 0.30.0. The likelihood ratio test was used to calculate 
statistical significance and the Wald test was used to calculate the beta values of transcripts, analogous to 
fold change. A volcano plot of -log10(pval) against log2(fold change) was generated using MATLAB and a 
heatmap representing the changes in expression of a curated set of these transcripts was created by 
uploading the TPM values to https://software.broadinstitute.org/morpheus/.  
 
Gene set enrichment analysis  
A gene set enrichment analysis (GSEA) was performed using the GSEA 4.0.0 (Broad Institute) software on 
the RNA-Seq data. All of the genes from the RNA-Seq data were used in the GSEA to identify gene sets 
enriched in a certain phenotypic class. Permutations of the phenotype or genotype labels are used to 
calculate the statistical significance of a gene sets enrichment score (Subramanian et al., 2005). Following 
instructions on the Broad Institute website (software.broadinstitute.org/gsea) an expression dataset file 
(.gct) was created containing the TPM values for each transcript, and a phenotype labels file (.cls) was 
created to label the phenotype of each sample. The Zebrafish.chip file was used to translate zebrafish 
transcript names to HUGO (Human Genome Organisation) gene symbols. GSEA was then performed to 
detect enriched HALLMARK gene sets from the Molecular Signature Database (Broad Institute). Gene set 
permutation was used to assess statistical significance of the enrichment scores as the number of samples 
in a phenotype was less than 7 (software.broadinstitute.org/gsea). Gene sets with a normalised enrichment 
score (NES) ≥ 1.5, FDR q-value ≤ 0.05 and nominal p-value ≤ 0.05 were considered statistically significant. 
 
Video capture 
An Aquatics Habitat breeding tank was modified to record zebrafish swimming whilst keeping the fish in 
frame and eliminating any reflection and shadow. To achieve this a white plastic insert of 145mm x 90mm 
was designed to fit the bottom of the tank and a hollow square frustum with openings at the top and 
bottom was created with a camera fitted above (Fig. 3A). The insert allowed for background subtraction 
and the frustum kept the fish in frame and reduced reflections and shadows. A raised platform on the lid 
positions the camera such that the fish remain in frame at all times. Following an acclimation time of 10 
minutes, zebrafish were recorded for 5 minutes. Recordings were carried out between the hours of 2pm 
and 5pm using a GoPro Hero 3 (GoPro, Inc., San Mateo, California, U.S.) at 100 frames per second at a 
resolution of 1280 × 720 pixels.  
 
Extracting data  
The computational processing resources required to analyse a full 5 minute recording are prohibitive and 
previous work on assessing movement disorders in humans found that 30 second samples were sufficient 
(Lones et al., 2013). Consequently, two 30 second clips were selected for processing from the first half and 
second half of the 5 minute recording using bespoke ShadowFish tracking software. Inspired by methods 
used for larval fish (Budick and O’Malley, 2000), this software was written by the authors to identify the fish 
using background subtraction and trace its midline, dividing it into 6 parts of equal length (Figure 3B). For 
each frame of recording, the absolute x and y coordinates of the 2 end points and 5 vertices along the spine 
are extracted, in addition to the angle at each vertex. This produces 5 bend angles and 7 x,y coordinates 
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from each frame. ShadowFish automatically determines lateral orientation of the fish by the direction of 
movement and therefore the normalised bending angle can be determined accordingly. Each processed 
video clip was visually assessed before being used to calculate the features of movement or evolve a 
classifier. Any clip where the fish was out of the field of view, or the ShadowFish tracking software 
misidentified a reflection or shadow of the zebrafish for the fish itself, was removed. The extracted 
movement data is written to a comma-separated values (CSV) file.   
 
Calculating features of movement 
MATLAB (The Mathworks, Inc., Natick, Massachusetts, U.S.) was used to calculate features of movement, 
inspired by previous studies (Supplementary data, Table 4), from the extracted raw movement data. The 
distance travelled by a zebrafish in a recording was determined by taking the absolute coordinates of the 
fish every 100 frames and using the Pythagoras theorem to work out the distance covered in between. It 
was necessary to establish when a fish was stationary so data points at those times were not included in 
certain calculations of features. When a fish travelled less than 5mm over a one second period it was 
classed as stationary for that second. The time spent moving was the number of seconds in a clip that the 
fish travelled over 5mm out of the total 30 seconds, displayed as a percentage. The mean velocity was 
calculated by dividing the distance travelled by the number of seconds spent moving. Swimming episode 
duration was how long a fish was classed as moving before a stationary period. To study the tail beat 
frequency of a zebrafish in a recording, the sum of the 5 angles along the spine was plotted over time. A 5-
frame moving average was also used to help reduce any noise in the angles from the raw data. The points 
of maximum tail bend were identified as the peaks on the plot. Only peaks with a minimum prominence of 
5 degrees and a minimum separation of 5 frames were identified, to leave out spikes in the data that were 
unlikely to be full tail bends. Tail bend amplitudes were the angles identified at the peaks of the plot. Tail 
beat frequencies and tail bend amplitudes were also calculated at different speeds, in case a difference in 
movement phenotype was more apparent at a certain speed. Low-speed movement was defined as 0.5 ≤ X 
< 2cm/s. Medium-speed movement was defined as 2 ≤ X < 4cm/s and high-speed movement was ≥4cm/s. 
 
Methodology and statistics of movement data analyses 
Multiple features of movement were extracted from the mutant and wildtype fish and all parameters that 
were measured have been reported. In order to raise and film the numbers of fish required for movement 
analyses two or more in-crossings of F4 homozygous mutants or homozygous wildtype siblings were carried 
out. Statistical analysis of the comparison of movement in wildtype and mutant fish produced the p-values 
quoted, derived from either a Student’s t-test, if the data was found to be normally distributed, or a Mann-
Whitney U test if the data was nonparametric. Statistical analyses were carried out using GraphPad Prism5 
to assess differences in the features of movement for mutant zebrafish and age-matched controls. Any 
features extracted that contained no numerical value were removed prior to analysis. For example, if a fish 
only travelled at low and medium speed in a clip then the high speed tailbeat frequency extracted would 
contain no numerical value and would therefore be left out of future analyses. The features containing 
numerical values were then examined using the Shapiro-Wilk test to see whether they followed a normal 
distribution. If the data followed a normal distribution the interquartile range (IQR) was used to identify 
suspected outliers. Any values at least 1.5 x IQR below the lower quartile or greater than the upper quartile 
were identified as outliers and removed prior to statistical analysis. This criteria for excluding outliers was 
established to remove fish that failed to swim in a clip, without swimming a fish contributes no real 
movement data to the analysis. Features were compared between classes using either a Student’s t-test if 
the data was normally distributed or a Mann-Whitney U test if the data was nonparametric. The 
investigator was not blinded to the genotype of zebrafish during video capture, however, when evolving 
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classifiers the extracted features, or principal component values, fish were randomly organised into the 
three data sets: training, validation and test and so the investigator was blinded to the genotype of fish 
when evolving a classifier. 
 
 
Training classification models 
Principal Component Analysis (PCA) was used to transform the multivariate time series of bend angles into 
a univariate time series suitable for classification. A type of evolutionary algorithm called implicit context 
representation Cartesian Genetic Programming (IRCGP) has been effective at classifying PD movement in 
humans (Lones et. al., 2017) by finding mathematical expressions that describe patterns of movement 
indicative of dyskinesia.  This approach was used to train classifiers to discriminate the features of 
movement from PC2 time series data of dj-1
-/-
 fish from those of wild-type controls. Sliding window 
classifiers trained using the PC2 time series data generate symbolic mathematical expressions that describe 
discriminatory local patterns of movement within the data. The classifiers were trained using a stochastic 
optimisation algorithm and this was repeated multiple times (20) to generate multiple models. The 
features of movement and PC2 time series data from each recording were organised into three data sets: 
training, validation and test. To train classifiers with the features of movement 60% of the recordings went 
into the training set, used to evaluate the effectiveness of classifiers during training. The remaining 40% of 
recordings were split equally between the validation and test sets. This split of the dataset proved the most 
effective to classify extracted features of movement. With a lower number of overall recordings used to 
train the CGP classifier it made more sense to have a higher number in the training data set. Aiming for a 
high number of clips to train the classifier allows it to recognise a common movement pattern. Whereas 
classifiers trained with the PC2 time series data had 50% of the recordings in the training set, 25% in the 
validation set and 25% in the test set. The sliding window classifier was evolved with a higher number of 
clips so more of the clips could go in the validation and test sets. This split of data was found best for 
evolving the most effective sliding window classifier. The validation set was used both for early stopping 
(i.e. to stop training when a model began to overfit the data) and to select the most general classifier from 
the multiple models generated during training. The test set was used to get an unbiased measure of the 
selected model’s discriminatory power. The tracking data was visually assessed to make sure it was of a 
high quality and the number of clips used in each class are shown in the Supplemental data, Tables 5 and 6.  
The sliding window classifiers were evolved using the area under the curve (AUC) as a measure of fitness 
which is not sensitive to class imbalances. 
 
Data availability 
The data from the RNA-Seq analysis has been deposited in NCBI's Gene Expression Omnibus (Edgar, 
Domrachev and Lash, 2002) with accession number GSE135271 (https://www.ncbi.nlm.nih.gov/geo). The 
ShadowFish tracking software and MATLAB code to extract the features of movement can be accessed 
online at github.com/ghughesyork/ShadowFish. 
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FIGURE LEGENDS 
 
Figure 1. The zebrafish dj-1
 -/-
 mutation is a genetic null 
(A) Wild-type dj-1 target sequence in the zebrafish genome (top). The 20 bp target sequence (blue) is 
directly upstream of a 3bp PAM site (red). A 2bp deletion (ΔCC) followed by a 19 bp insertion in the target 
sequence causes a frameshift mutation in dj-1 (bottom). (B) Comparison of the protein structure for wild-
type DJ-1 (top), with essential residue C106 indicated, and the predicted mutant protein truncated at 
residue 57 (bottom). (C) Western blot analysis of DJ-1 protein expression in the brains of wild-type adult 
zebrafish (lanes 1-4) and their dj-1
-/- 
mutant siblings (lanes 5-7). GAPDH was used as a loading control.   (D) 
qRT-PCR analysis (single replicate) comparing gene expression in brains extracted from wild-type adult 
zebrafish (n = 3, biological replicates) and their dj-1
-/- 
mutant siblings (n = 5) at 16 wpf. Target gene dj-1 was 
analysed alongside dopamine neuron markers dat (dopamine transporter), th (tyrosine hydroxylase) and 
pitx3 (pituitary homeobox 3), syn2a (synapsin IIa) acted as a general synapse marker. Student t-tests (two-
tailed) were used to compare the ΔCT values for dj-1
-/- 
and wild-type samples. Error bars are mean±s.e.m. 
, * = P < 0.05, *** = P < 0.001, ns = not significant.  
 
Figure 2. A reduction of dopaminergic neurons in the posterior tuberculum of PD zebrafish 
Immunohistochemical detection of Tyrosine Hydroxylase (TH)  in dj-1
-/-
 and PINK1
-/-
 brains. A section 
through the posterior tuberculum was identified based on the shape of the brain according to Wulliman, 
Rupp and Reichert (1996). The large pear-shaped TH-positive cells located next to the ventricle in the 
posterior tuberculum have previously been identified as part of the zebrafish dopaminergic system 
projecting to the striatum (Rink and Wulliman, 2001). Therefore, the pear-shaped TH positive cells 
identified in the periventricular posterior tuberculum location were counted. (A) The left diagram is a 
lateral view of the adult zebrafish brain. The right diagram is a cross section through the adult zebrafish 
brain. Highlighted in red is the posterior tuberculum (pT). (B-G, I-K) Immunofluorescently-labelled TH 
positive cells (green) in the pT of wild type, dj-1
-/-
 and PINK1
-/-
 zebrafish (n = 3 biological replicates) at 12 
mpf. Hoechst staining of nuclei is in blue. Arrows indicate the cell bodies of the paraventricular dopamine 
neurons. (B) TH positive cells in a section through the pT (red box) of a wild type brain. (C) A close-up of the 
TH positive cells in the pT from A. (D-E) TH positive cells in the sections of 3 different dj-1
-/-
 brains.  (D) TH 
positive cells in a section through the pT (red box) of a dj-1
-/-
 brain.  (E) A close up of the TH positive cells in 
the pT from D. (F,G) Close ups of TH positive cells in the pT of two further dj-1
-/-
 brains. (H)  i - CRISPR/Cas9 
target sequences (blue), PAM sites (red) and the 101bp deletion generated in exon 2 of PINK1 (at position 
591 of NM_001008628).  ii - Wild type PINK1 (above) and the truncated PINK1 protein (below) predicted in 
the PINK1 mutant. iii - qRT-PCR analysis comparing PINK1 expression in brains extracted from PINK1
-/-
 
zebrafish (n=4, biological replicates) and wild type siblings (n=3) at 16 wpf. Student t-tests (two-tailed) were 
used to compare the ΔCT values for PINK1
-/-
 and wild-type samples. Error bars are mean±s.e.m., *** = 
P<0.001. (I) TH positive cells in a section through the pT (red box) of a PINK1
-/-
 brain. (J) A close up of the TH 
positive cells in the pT from I. (K) A close up of the TH positive cells in the pT of a further PINK1
-/-
 brain. (L) 
Counts of TH positive cell bodies seen in the pT (single 100µm section) for wild type, dj-1-/- and PINK1-/- 
zebrafish (n=3 biological replicates) at 12 mpf. 
 
Figure 3. Analysis of extracted features reveals distinct movement in dj-1
 -/- 
zebrafish 
(A) A photograph of the frustum insert designed to fit an Aquatics Habitat mating tank with a GoPro camera 
attached (left), providing a simple system for accurate, high-resolution video capture of adult zebrafish 
movement. A diagram of the fish inside the frustrum insert, recorded from above using the GoPro camera 
(right). (B) A diagram of the angles measured along the zebrafish trace, at the 5 vertices (red), when there is 
a bend in the tail. x and y coordinates were measured for the vertices and endpoints. Measurements were 
recorded at 100 frames per second from the video input allowing analysis of selected features of 
movement. The features of movement compared between dj-1
-/- 
and wild-type (WT) at 12 wpf including (C) 
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distance travelled, (D) velocity, (E) percentage of time spent moving, (F) mean duration of a swimming 
episode, (G) tail beat frequency at low, medium and high swimming speeds, (H) tail bend amplitude at low, 
medium and high swimming speeds (single replicate). The number of replicates (n) is shown for each graph. 
Student t-tests (two-tailed) were used to compare features that followed a normal distribution, the Mann-
Whitney U test (two-tailed) was used to compare nonparametric features. Error bars are mean±s.e.m., * = 
P < 0.05, ** = P < 0.01, *** = P < 0.001, ns = not significant.  
 
Figure 4. Machine learning evolves classifiers from movement data and discriminates dj-1
-/-
 zebrafish as 
distinct from controls 
(i) An analysis using an evolutionary algorithm to discriminate a classifier by analysing extracted features of 
movement (A-C) (A) The mean training and test scores for classifiers evolved to recognise dj-1
-/- 
zebrafish 
(n=30) at 12 wpf over 20 folds of datasets containing extracted features of movement. The CGP network of 
the highest scoring dj-1
-/- 
classifier evolved using the extracted features is depicted as a flow diagram. (B) 
The mean training and test scores for classifiers evolved to recognise PINK1
 -/-
 zebrafish (n=37) at 14 wpf 
over 20 folds of dataset containing extracted features of movement. The CGP network of the highest 
scoring PINK1
 -/-
 classifier evolved using the extracted features is depicted as a flow diagram. (C) The mean 
training and test scores for classifiers evolved to recognise dmd
ta222a/+ 
zebrafish (n=25) at 12 wpf over 20 
folds of dataset containing extracted features of movement. The CGP network of the highest scoring 
dmd
ta222a/+ 
classifier evolved using the extracted features is depicted as a flow diagram. (ii) A separate 
analysis of the raw movement data using sliding window classifiers trained with the PC2 time series data to 
generate symbolic mathematical expressions that describe discriminatory local patterns of movement 
within the data. (D-E): (D) The training and test accuracies for the classifier evolved to recognise dj-1
-/-
 
zebrafish at 12 wpf. Mean plots of the PC2 time series data in the 20 windows most useful for 
discriminating dj-1
-/-
 mutants (n=36) (red) and age matched controls (n=64) (black) in the test dataset. (E) 
The training and test accuracies for the classifier evolved to recognise PINK1
 -/-
 zebrafish at 14 wpf. Mean 
plots of the PC2 time series data in the 20 windows most useful for discriminating PINK1
 -/-
 mutants (n=39) 
(red) and age matched controls (n=44) (black) in the test dataset.  
 
Figure 5. Differential gene expression in the dj-1
 -/-
 mutant brain 
(A) A volcano plot representing the global changes in gene expression observed by RNA-Seq analysis 
comparing RNA from the brains of dj-1
-/-
 mutants (n = 3, biological replicates) and their wild-type siblings (n 
= 3) at 16 wpf. The fold change (log2) of each transcript was plot against the P-value (-log10). Transcripts in 
red are down/up-regulated less than 2 folds. Transcripts in orange that appear above the dotted line are 
differentially expressed with a P-value of <0.05 and down/up-regulated more than 2 folds. Transcripts in 
blue have a P-value of >=0.05. (B) A heatmap showing select genes differentially expressed with a Q-value 
of <0.05. Relative expression is represented on a colour scale from blue (low) to orange (high). (C) qRT-PCR 
analysis validating the results seen in the RNA-Seq using RNA extracted from the brains of dj-1
-/-
 and wild-
type siblings at 16 wpf (n=3 for all but n=5 for kcnk analysis, biological replicates). Student t-tests (two-
tailed) were used to compare the ΔCT values for dj-1
-/-
 and wild-type samples. Error bars are mean ±s.e.m., 
* = P < 0.05, ** = P < 0.01, *** = P < 0.001. (D) GSEA enrichment plots for Hallmark gene sets: G2M 
checkpoint, oxidative phosphorylation, E2F transcription factors and PI3K/AKT/mTOR signalling. NES = 
normalised enrichment score. FDR = false discovery rate adjusted P-value. P = nominal P-value. Data has 
been deposited in GEO; accession number GSE135271.  





